Invention Grant
- Patent Title: Two-part device for T-cell receptor synthesis and stable genomic integration to TCR-presenting cells
-
Application No.: US16347723Application Date: 2017-11-07
-
Publication No.: US11274309B2Publication Date: 2022-03-15
- Inventor: Reagan Micheal Jarvis , Ryan Edward Hill , Luke Benjamin Pase
- Applicant: GENOVIE AB
- Applicant Address: SE Södertälje
- Assignee: GENOVIE AB
- Current Assignee: GENOVIE AB
- Current Assignee Address: SE Södertälje
- Agency: Foley & Lardner LLP
- Priority: DKPA201670875 20161107,DKPA201770577 20170718,EP17181798 20170718
- International Application: PCT/EP2017/078378 WO 20171107
- International Announcement: WO2018/083318 WO 20180511
- Main IPC: C12N15/63
- IPC: C12N15/63 ; C12Q1/6806 ; C12Q1/686 ; C12N15/10 ; C07K14/725
Abstract:
The present invention relates to a two-part device, wherein a first part is a multicomponent TCR ORF reconstitution and engineering system (TORES), and a second part is a multicomponent engineered TCR-presenting cell system (eTPCS).
Public/Granted literature
- US20190283017A1 A TWO-PART DEVICE FOR T-CELL RECEPTOR SYNTHESIS AND STABLE GENOMIC INTEGRATION TO TCR-PRESENTING CELLS Public/Granted day:2019-09-19
Information query
IPC分类:
